Md Bayazid Hossen
Overview
Explore the profile of Md Bayazid Hossen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarker A, Aziz M, Hossen M, Mollah M, Al-Amin , Haque Mollah M
Sci Rep
. 2024 Nov;
14(1):27545.
PMID: 39528802
Glioblastoma (GBM) is the most malignant brain cancer and one of the leading causes of cancer-related death globally. So, identifying potential molecular signatures and associated drug molecules are crucial for...
2.
Mahmud S, Ajadee A, Hossen M, Islam M, Ahmmed R, Ali M, et al.
Comput Biol Chem
. 2024 Oct;
113:108245.
PMID: 39454454
The most frequent endocrine cancer of the head and neck is thyroid carcinoma (THCA). Although there is increasing evidence linking THCA to genetic alterations, the exact molecular mechanism behind this...
3.
Ahmmed R, Hossen M, Ajadee A, Mahmud S, Ali M, Mollah M, et al.
Sci Rep
. 2024 Aug;
14(1):19133.
PMID: 39160196
Type 2 diabetes (T2D) and Clear-cell renal cell carcinoma (ccRCC) are both complicated diseases which incidence rates gradually increasing. Population based studies show that severity of ccRCC might be associated...
4.
Alamin M, Rahaman M, Ferdousi F, Sarker A, Ali M, Hossen M, et al.
PLoS One
. 2024 Jul;
19(7):e0304425.
PMID: 39024368
COVID-19 caused by SARS-CoV-2 is a global health issue. It is yet a severe risk factor to the patients, who are also suffering from one or more chronic diseases including...
5.
Hossen M, Reza M, Rana M, Hossen M, Shoaib M, Haque Mollah M, et al.
Chin Clin Oncol
. 2024 Jul;
13(3):32.
PMID: 38984486
Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths globally. To reduce HCC-related mortality, early diagnosis and therapeutic improvement are essential. Hub differentially expressed genes (HubGs) may...
6.
Tuly K, Hossen M, Islam M, Kibria M, Alam M, Harun-Or-Roshid M, et al.
Medicina (Kaunas)
. 2023 Oct;
59(10).
PMID: 37893423
Breast cancer (BC) is one of the major causes of cancer-related death in women globally. Proper identification of BC-causing hub genes (HubGs) for prognosis, diagnosis, and therapies at an earlier...
7.
Islam M, Kibria M, Hossen M, Reza M, Tasmia S, Tuly K, et al.
Sci Rep
. 2023 Mar;
13(1):4685.
PMID: 36949176
Some recent studies showed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and idiopathic pulmonary fibrosis (IPF) disease might stimulate each other through the shared genes. Therefore, in this...
8.
Islam M, Hossen M, Horaira M, Hossen M, Kibria M, Reza M, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900162
Colorectal cancer (CRC) is one of the most common cancers with a high mortality rate. Early diagnosis and therapies for CRC may reduce the mortality rate. However, so far, no...
9.
Hossen M, Islam M, Reza M, Kibria M, Horaira M, Tuly K, et al.
Comput Biol Med
. 2022 Dec;
152:106411.
PMID: 36502691
Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So, identification of potential molecular signatures is required for diagnosis, prognosis, and therapies of PC. In this...
10.
Mosharaf M, Kibria M, Hossen M, Islam M, Reza M, Mahumud R, et al.
Vaccines (Basel)
. 2022 Aug;
10(8).
PMID: 36016137
The pandemic of SARS-CoV-2 infections is a severe threat to human life and the world economic condition. Although vaccination has reduced the outspread, but still the situation is not under...